Mitra, Koushambi https://orcid.org/0000-0003-4325-453X
Kim, Soyoung https://orcid.org/0000-0001-7681-106X
Oettinger, Daphne
Uthishtran, Sanjeev https://orcid.org/0000-0001-8538-3482
Zhao, Qian https://orcid.org/0000-0002-2918-2077
Veetil, Aneesh Tazhe
Ramirez, Joseph R.
Lin, Hening https://orcid.org/0000-0002-0255-2701
Arumugam, Senthil https://orcid.org/0000-0001-6733-4679
Krishnan, Yamuna https://orcid.org/0000-0001-5282-8852
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (DP1GM149751)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (1R01NS112139-01A1)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (1R21NS114428-01)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (1R01GM147197-01)
Article History
Received: 29 July 2024
Accepted: 15 May 2026
First Online: 22 June 2026
Competing interests
: Y.K. is a cofounder of Esya and MacroLogic that use DNA nanodevices to develop diagnostics and therapeutics, respectively. The other authors declare no competing interests.